Ciprofibrate is a fibrate derivative functioning as a lipid-lowering agent primarily used to treat hyperlipidemia by inhibiting hepatic cholesterol synthesis. The compounds available within this category… Read more












Ciprofibrate is a fibrate derivative functioning as a lipid-lowering agent primarily used to treat hyperlipidemia by inhibiting hepatic cholesterol synthesis. The compounds available within this category include the active pharmaceutical ingredient alongside its related impurities, metabolites, and stable isotope-labelled standards, all of which are essential for rigorous analytical testing. These reference materials enable precise impurity profiling, method validation, and long-term stability studies, ensuring compliance with both internal quality control protocols and regulatory guidelines. By utilizing these structurally characterized standards, such as specific esters and degradation products, laboratories can effectively monitor the potency and safety of drug formulations. Stable isotope-labelled compounds further support accurate quantification in complex matrices, providing researchers with reliable tools for pharmaceutical development and quality assurance processes.